Recent NVCR News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 12:00:33 PM
- Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update • Business Wire • 01/13/2025 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 09:10:42 PM
- Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/03/2025 12:00:00 PM
- Novocure annonce des résultats positifs de l'essai clinique de phase 3 PANOVA-3 sur les champs de traitement des tumeurs (TTFields) pour le cancer du pancréas • Business Wire • 12/05/2024 06:00:00 AM
- Novocure gibt positive Ergebnisse der Phase-3-Studie PANOVA-3 zur Tumor Treating Fields (TTFields)-Therapie bei Bauchspeicheldrüsenkrebs bekannt • Business Wire • 12/05/2024 06:00:00 AM
- ノボキュア、膵がんに対する腫瘍治療電場療法(TTフィールド)の第3相臨床試験PANOVA-3のトップライン結果を発表 • Business Wire • 12/04/2024 10:00:00 PM
- Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer • Business Wire • 12/02/2024 12:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2024 12:00:16 PM
- Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer • Business Wire • 12/02/2024 12:00:00 PM
- Novocure to Participate in Upcoming Investor Conferences • Business Wire • 11/27/2024 12:00:00 PM
- Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma • Business Wire • 11/21/2024 12:05:00 PM
- FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma • Business Wire • 11/21/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 09:27:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:32:28 PM
- Novocure meldet Finanzergebnisse des dritten Quartals 2024 • Business Wire • 10/31/2024 02:36:00 PM
- ノボキュア、2024年度第3四半期の決算を発表 • Business Wire • 10/31/2024 02:36:00 PM
- Novocure présente ses résultats financiers pour le troisième trimestre 2024 • Business Wire • 10/31/2024 02:36:00 PM
- ノボキュア、クリストフ・ブラクマン氏を最高財務責任者(CFO)に任命 • Business Wire • 10/31/2024 11:07:00 AM
- Novocure nomme Christoph Brackmann au poste de directeur financier • Business Wire • 10/31/2024 11:07:00 AM
- Novocure ernennt Christoph Brackmann zum Finanzvorstand • Business Wire • 10/31/2024 03:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 11:02:07 AM
- Novocure Appoints Christoph Brackmann as Chief Financial Officer • Business Wire • 10/30/2024 11:02:00 AM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM